NCT05715749

Brief Summary

The goal of this pilot interventional study is to learn about the use of an in-home harness system in children who have been treated for spinal muscular atrophy. The main questions it aims to answer are:

  1. 1.Is the in-home body weight support harness system a feasible option for families to use?
  2. 2.Is the in-home body weight support harness system a useful tool for children treated for spinal muscular atrophy?
  3. 3.Is the in-home body weight support harness system a safe tool for children treated for spinal muscular atrophy?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 7, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2020

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

January 20, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 8, 2023

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2024

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

1.8 years

First QC Date

January 20, 2023

Last Update Submit

July 18, 2024

Conditions

Keywords

exercisephysical therapy

Outcome Measures

Primary Outcomes (6)

  • Caregiver survey

    A five question likert-style survey asking families to rate their experience during the study. The scales asks the family to rate (1) the perceived impact of BWSS on motor and (2) non-motor skills, (3) the child's perceived enjoyment using the system, (4) the ease of equipment use, and (5) if the family believed that use of the BWSS was beneficial on a 5-point Likert scale; scores of 4 or 5 were considered favorable, scores of 3 were considered neutral, and scores of 1 or 2 were considered unfavorable. Higher scores indicate greater perceived benefit of participation.

    End of study visit (month 6)

  • Change in The Neuromuscular Gross Motor Outcome (GRO) scale

    A 50-item performance-based outcome developed to quantify motor function across the span of age and abilities in individuals with neuromuscular disorders including spinal muscular atrophy (SMA). Scores range from 0 - 100 points; higher scores reflect a greater level of function. An increase in score indicates a better outcome.

    Completed at baseline, 3 months, and 6 months

  • Change in Hammersmith Functional Motor Scale Expanded (HFMSE)

    A disease-specific and performance-based outcomes originally developed to measure motor skill in untreated individuals with SMA. Scores range from 0 - 66 points; higher scores reflect a greater level of function. An increase in score indicates a better outcome.

    Completed at baseline, 3 months, and 6 months

  • Change in Revised Hammersmith Scale (RHS)

    A disease-specific and performance-based outcomes originally developed to measure motor skill in untreated individuals with SMA, revised following Rasch analysis of HFMSE. Scores range from 0 - 69 points; higher scores reflect a greater level of function. An increase in score indicates a better outcome.

    Completed at baseline, 3 months, and 6 months

  • Change in Bayley Scales of Infant and Toddler Development 3rd ed. (Bayley-III), Gross motor subtest

    A norm-referenced developmental assessment of gross motor skill in children 16 days - 3.5 years of age. Raw scores range from 0 - 72. Higher scores indicate a greater level of funcion. An increase in score indicates a better outcome.

    Completed at baseline, 3 months, and 6 months

  • Change in World Health Organization Motor Milestone Checklist

    A checklist of key gross motor milestones expected during typical development. Scores can range from 0 - 6 milestones achieved. Achievement of a greater number of milestones indicates better outcomes.

    Completed at baseline, 3 months, and 6 months

Secondary Outcomes (1)

  • Harness use log

    Completed throughout 6-month study period

Study Arms (1)

In-home body weight support harness system

EXPERIMENTAL

All participants will be entered into treatment arm and receive an in-home body weight support harness system

Other: In-home body weight support harness system

Interventions

A portable, adjustable body weight support harness system that occupies roughly 9 feet x 9 feet space in the home. The system allows 360 degrees of mobility anywhere within the footprint of the frame. The amount of body weight support is adjustable.

Also known as: The Portable Mobility Aid for Children (PUMA)
In-home body weight support harness system

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed heterozygous mutation in SMN1 gene and 2 or 3 copies of SMN2 (historically, SMA Type 1 and Type 2)
  • Past or current treatment with nusinersen, onasemnogene abeparvovec, or risdiplam
  • Upright head control (defined as the ability to lift head from full forward flexion)
  • Weight under or 50lbs
  • Confirmed motor delay

You may not qualify if:

  • + copies of SMN2 (historically, SMA Type 3 and 4)
  • Evidence of lower limb injury or recent fracture
  • In the opinion of the investigator, it was unsafe for the child to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

Related Publications (1)

  • Iammarino MA, Alfano LN, Reash NF, Sabo B, Conroy S, Noritz G, Wendland M, Lowes LP. Feasibility and utility of in-home body weight support harness system use in young children treated for spinal muscular atrophy: A single-arm prospective cohort study. PLoS One. 2024 Mar 19;19(3):e0300244. doi: 10.1371/journal.pone.0300244. eCollection 2024.

MeSH Terms

Conditions

Spinal Muscular Atrophies of ChildhoodMotor Activity

Interventions

bbc3 protein, zebrafish

Condition Hierarchy (Ancestors)

Muscular Atrophy, SpinalSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesMotor Neuron DiseaseNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBehavior

Study Officials

  • Megan A Iammarino, DPT

    Nationwide Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Outcomes assessors are masked to previous participant performance.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Physical Therapist

Study Record Dates

First Submitted

January 20, 2023

First Posted

February 8, 2023

Study Start

September 7, 2018

Primary Completion

June 15, 2020

Study Completion

July 15, 2024

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Participant data will be provided in summary form at manuscript submission. Certain individual participant data will be available in manuscript as well.

Locations